Newsroom

  • Category

  • Press Release

    10 July 23

    CuraTeQ Biologics to market Ustekinumab biosimilar to treat Crohn’s disease, arthritis

    Read more
  • Press Release

    05 July 23

    CuraTeQ Biologics announces positive Phase-3 results for Trastuzumab biosimilar

    Read more